BackgroundIn the UK, a process of revalidation is being introduced to allow doctors to demonstrate that they meet current professional standards, are up-to-date, and fit to practise. Given the serious risks to patients from hazardous use of medicines it will be appropriate, as part of the revalidation process, to assess the safety of prescribing by GPs.
AimTo identify a set of potential prescribing-safety indicators for the purposes of revalidation of individual GPs in the UK.
Design and settingThe RAND Appropriateness Method was used to identify, develop, and obtain agreement on the indicators in UK general practice.
MethodTwelve GPs from across the UK with a wide variety of characteristics assessed indicators for appropriateness of use in revalidation.
ResultsForty-seven safety indicators were considered appropriate for assessing the prescribing safety of individual GPs for the purposes of revalidation (appropriateness was defined as an overall panel median score of ≥7 (on a 1-9 scale), with no more than three panel members rating the indicator outside the 3-point distribution around the median]. After removing indicators that were variations on the same theme, a final set of 34 indicators was obtained; these cover hazardous prescribing across a range of therapeutic areas, hazardous drugdrug combinations, prescribing with a history of allergy, and inadequate laboratory-test monitoring.
ConclusionThis study identified a set of 34 indicators that were considered, by a panel of 12 GPs, to be appropriate for use in assessing the safety of GP prescribing for the purposes of revalidation. Violation of any of the 34 indicators indicates a potential patient-safety problem.
Introduction: The pathophysiology of extrapyramidal side effects of typical antipsychotic drugs and the role of gender as a risk factor is poorly understood. Objectives: To elucidate the role of gender and the oestrogen hypothesis in extrapyramidal side effect severity. Aims: To investigate gender differences in side effects of antipsychotic drugs and explore the role of oestrogen levels in side effect severity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.